Antibodies in the pathogenesis of hypertension

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Chan, Christopher T ^a   Lieu, Maggie ^a   Toh, Ban Hock ^a   Kyaw, Tin S ^b   Bobik, Alexander ^b   Sobey, Christopher G ^a   Drummond, Grant R ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ANTIBODY; BETA 1 ADRENERGIC RECEPTOR; CALCIUM ION; G PROTEIN COUPLED RECEPTOR; HEAT SHOCK PROTEIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; ION CHANNEL; SODIUM ION; VOLTAGE GATED CALCIUM CHANNEL;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ANTIHYPERTENSIVE THERAPY; AUTOIMMUNE DISEASE; B LYMPHOCYTE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CELL FUNCTION; ESSENTIAL HYPERTENSION; EXPERIMENTAL HYPERTENSION; HEART OUTPUT; HUMAN; HYPERTENSION; IMMUNE RESPONSE; MATERNAL HYPERTENSION; MOLECULAR MIMICRY; NONHUMAN; PATHOGENESIS; PHASE 3 CLINICAL TRIAL (TOPIC); REVIEW; TREATMENT INDICATION; VASCULAR RESISTANCE; WATER ABSORPTION; ANIMAL; IMMUNOLOGY;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; B-LYMPHOCYTES; HUMANS; HYPERTENSION;

EID: 84904178302     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/504045     Document Type: Review

References (97)

1. Ebringer A., Doyle A. E., Raised serum IgG levels in hypertension. British Medical Journal 1970 2 5702 146 148 2-s2.0-0014953707
2. Suryaprahba P., Padma T., Brahmaji Rao U., Increased serum IgG levels in essential hypertension. Immunology Letters 1984 8 3 143 145 2-s2.0-0021208338 10.1016/0165-2478(84)90067-1 (Pubitemid 14031491)
3. Hilme E., Herlitz H., Soderstrom T., Hansson L., Increased secretion of immunoglobulins in malignant hypertension. Journal of Hypertension 1989 7 2 91 95 2-s2.0-0024601637 (Pubitemid 19073983)
4. Gudbrandsson T., Hansson L., Herlitz H., Lindholm L., Nilsson L. A., Immunological changes in patients with previous malignant essential hypertension. Lancet 1981 1 8217 406 408 2-s2.0-0019382227 10.1016/S0140- 6736(81)91790-6 (Pubitemid 11188931)
5. Lebien T. W., Tedder T. F., B lymphocytes: How they develop and function. Blood 2008 112 5 1570 1580 2-s2.0-47249099558 10.1182/blood-2008-02-078071
6. Parker D. C., T cell-dependent B cell activation. Annual Review of Immunology 1993 11 331 360 2-s2.0-0027450354 (Pubitemid 23115011)
7. Grewal I. S., Flavell R. A., CD40 and CD154 in cell-mediated immunity. Annual Review of Immunology 1998 16 111 135 2-s2.0-0031944607 10.1146/annurev.immunol.16.1.111 (Pubitemid 28183361)
8. Purkerson J., Isakson P., A two-signal model for regulation of immunoglobulin isotype switching. The FASEB Journal 1992 6 14 3245 3252 2-s2.0-0026465192
9. Tangye S. G., Ferguson A., Avery D. T., Ma C. S., Hodgkin P. D., Isotype switching by human B cells is division-associated and regulated by cytokines. Journal of Immunology 2002 169 8 4298 4306 2-s2.0-0037108509 (Pubitemid 35178202)
10. Gehrs B. C., Friedberg R. C., Autoimmune hemolytic anemia. The American Journal of Hematology 2002 69 4 258 271 2-s2.0-0036210260 10.1002/ajh.10062 (Pubitemid 34259848)
11. Theofilopoulos A. N., Dixon F. J., Immune complexes in human diseases. The American Journal of Pathology 1980 100 2 529 594 2-s2.0-0019313196 (Pubitemid 10037092)
12. Koffler D., Agnello V., Thoburn R., Kunkel H. G., Systemic lupus erythematosus: prototype of immune complex nephritis in man. Journal of Experimental Medicine 1971 134 supplement 3 169S 179S 2-s2.0-0015124633
13. Gross W. L., Trabandt A., Reinhold-Keller E., Diagnosis and evaluation of vasculitis. Rheumatology 2000 39 3 245 252 2-s2.0-0034108970 (Pubitemid 30204207)
14. Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D., Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology 1998 51 4 933 2-s2.0-17744416538 (Pubitemid 28473376)
15. Schwimmbeck P. L., Dyrberg T., Drachman D. B., Oldstone M. B. A., Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor -subunit that has biologic activity and reacts immunochemically with herpes simplex virus. Journal of Clinical Investigation 1989 84 4 1174 1180 2-s2.0-0024429029 (Pubitemid 19247588)
16. Ba D., Takeichi N., Kodama T., Kobayashi H., Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. Journal of Immunology 1982 128 3 1211 1216 2-s2.0-0020040957 (Pubitemid 12188439)
17. White F. N., Grollman A., Autoimmune factors associated with infarction of the kidney. Nephron 1964 204 93 102 2-s2.0-0042417593
18. Peach M. J., Renin angiotensin system: biochemistry and mechanisms of action. Physiological Reviews 1977 57 2 313 370 2-s2.0-0017413556 (Pubitemid 8097628)
19. Hunyady L., Catt K. J., Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Molecular Endocrinology 2006 20 5 953 970 2-s2.0-29344452247 10.1210/me.2004-0536
20. Silva-Filho J. L., Souza M. C., Henriques M. D. G., Morrot A., Savino W., Nunes M. P., Caruso-Neves C., Pinheiro A. A. S., AT1 receptor-mediated angiotensin II activation and chemotaxis of T lymphocytes. Molecular Immunology 2011 48 15-16 1835 1843 2-s2.0-80051928132 10.1016/j.molimm.2011.05.008
21. Wallukat G., Homuth V., Fischer T., Lindschau C., Horstkamp B., Jüpner A., Baur E., Nissen E., Vetter K., Neichel D., Dudenhausen J. W., Haller H., Luft F. C., Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. Journal of Clinical Investigation 1999 103 7 945 952 2-s2.0-0032924922 (Pubitemid 29169601)
22. Siddiqui A. H., Irani R. A., Blackwell S. C., Ramin S. M., Kellems R. E., Xia Y., Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity. Hypertension 2010 55 2 386 393 2-s2.0-74949106574
23. Xia Y., Kellems R. E., Angiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyond. Circulation Research 2013 113 1 78 87 2-s2.0-84880310628 10.1161/CIRCRESAHA.113.300752
24. Zhou C. C., Irani R. A., Dai Y., Blackwell S. C., Hicks M. J., Ramin S. M., Kellems R. E., Xia Y., Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. Journal of Immunology 2011 186 10 6024 6034 2-s2.0-79956218173 10.4049/jimmunol.1004026
25. Irani R. A., Zhang Y., Zhou C. C., Blackwell S. C., Hicks M. J., Ramin S. M., Kellems R. E., Xia Y., Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor- signaling. Hypertension 2010 55 5 1246 1253 2-s2.0-77951498022 10.1161/HYPERTENSIONAHA. 110.150540
26. Fu M. L., Herlitz H., Schulze W., Wallukat G., Micke P., Eftekhari P., Sjögren K.-G., Hjalmarson Å., Müller-Esterl W., Hoebeke J., Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. Journal of Hypertension 2000 18 7 945 953 2-s2.0-0033911364 (Pubitemid 30459497)
27. Zhu F., Sun Y., Wang M., Ma S., Chen X., Cao A., Chen F., Qiu Y., Liao Y., Correlation between HLA-DRB1, HLA-DQB1 polymorphism and autoantibodies against angiotensin AT(1) receptors in Chinese patients with essential hypertension. Clinical Cardiology 2011 34 5 302 308 2-s2.0-79955908602 10.1002/clc.20852
28. Liao Y. H., Wei Y. M., Wang M., Wang Z. H., Yuan H. T., Cheng L. X., Autoantibodies against AT1-receptor and 1-adrenergic receptor in patients with hypertension. Hypertension Research 2002 25 4 641 646 2-s2.0-0035993043 10.1291/hypres.25.641
29. Sun Y., Liao Y., Yuan Y., Influence of autoantibodies against AT1 receptor and AGTR1 polymorphisms on candesartan-based antihypertensive regimen: results from the Study of Optimal Treatment in Hypertensive Patients with Anti-AT1-Receptor Autoantibodies trial. Journal of the American Society of Hypertension 2014 8 1 21 27 10.1016/j.jash.2013.08.002
30. Wei F., Jia X. J., Yu S. Q., Gu Y., Wang L., Guo X. M., Wang M., Zhu F., Cheng X., Wei Y. M., Zhou Z. H., Fu M., Liao Y. H., Candesartan versus imidapril in hypertension: a randomised study to assess effects of anti-AT1 receptor autoantibodies. Heart 2011 97 6 479 484 2-s2.0-79952003366 10.1136/hrt.2009. 192104
31. Reid J. L., Alpha-adrenergic receptors and blood pressure control. The American Journal of Cardiology 1986 57 9 6E 12E 2-s2.0-0022553619 (Pubitemid 16048441)
32. Piascik M. T., Perez D. M., 1-adrenergic receptors: new insights and directions. Journal of Pharmacology and Experimental Therapeutics 2001 298 2 403 410 2-s2.0-0034742707 (Pubitemid 32673390)
33. Luther H. P., Homuth V., Wallukat G., 1-Adrenergic receptor antibodies in patients with primary hypertension. Hypertension 1997 29 2 678 682 2-s2.0-0031037595 (Pubitemid 27074736)
34. Fu M. L., Herlitz H., Wallukat G., Hilme E., Hedner T., Hoebeke J., Hjalmarson Å., Functional autoimmune epitope on 1-adrenergic receptors in patients with malignant hypertension. The Lancet 1994 344 8938 1660 1663 2-s2.0-0028005403 10.1016/S0140-6736(94)90456-1 (Pubitemid 24371095)
35. Wenzel K., Haase H., Wallukat G., Derer W., Bartel S., Homuth V., Herse F., Hubner N., Schulz H., Janczikowski M., Lindschau C., Schroeder C., Verlohren S., Morano I., Muller D. N., Luft F. C., Dietz R., Dechend R., Karczewski P., Potential relevance of 1-Adrenergic receptor autoantibodies in refractory hypertension. PLoS ONE 2008 3 11 2-s2.0-56749150002 10.1371/journal.pone.0003742 e3742
36. Minneman K. P., Pittman R. N., Molinoff P. B., Beta-adrenergic receptor subtypes: properties, distribution, and regulation. Annual Review of Neuroscience 1981 4 419 461 2-s2.0-0019502424
37. van Baak M. A., Struyker Boudier H. A. J., Smits J. F. M., Antihypertensive mechanisms of beta-adrenoceptor blockade: a review. Clinical and Experimental Hypertension A Theory and Practice 1985 7 1 1 72 2-s2.0-0021868629 (Pubitemid 15078044)
38. Wallukat G., Blasig I. E., Morwinski R., Herrmann H. J., Rohde E., The sera of spontaneously hypertensive rats contain agonistic auto-antibodies against the β 1-adrenoceptor. Journal of Hypertension 1995 13 9 1031 1036 2-s2.0-0028871639 10.1097/00004872-199509000-00014
39. Jahns R., Boivin V., Hein L., Triebel S., Angermann C. E., Ertl G., Lohse M. J., Direct evidence for a β 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. Journal of Clinical Investigation 2004 113 10 1419 1429 2-s2.0-2942532947 10.1172/JCI200420149 (Pubitemid 39071697)
40. Magnusson Y., Wallukat G., Waagstein F., Hjalmarson Å., Hoebeke J., Autoimmunity in idiopathic dilated cardiomyopathy: characterization of antibodies against the β 1-adrenoceptor with positive chronotropic effect. Circulation 1994 89 6 2760 2767 2-s2.0-0028225294 (Pubitemid 24173697)
41. Catterall W. A., Voltage-gated calcium channels. Cold Spring Harbor perspectives in biology 2011 3 8 a003947 2-s2.0-84856403567
42. Wilde D. W., Furspan P. B., Szocik J. F., Calcium current in smooth muscle cells from normotensive and genetically hypertensive rats. Hypertension 1994 24 6 739 746 2-s2.0-0028030025 (Pubitemid 24363972)
43. Cox R. H., Lozinskaya I. M., Augmented calcium currents in mesenteric artery branches of the spontaneously hypertensive rats. Hypertension 1995 26 6 1060 1064 2-s2.0-0028839630
44. Ohya Y., Tsuchihashi T., Kagiyama S., Abe I., Fujishima M., Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats. Hypertension 1998 31 5 1125 1129 2-s2.0-0031946348 (Pubitemid 28191507)
45. Simard J. M., Li X., Tewari K., Increase in functional Ca2+ channels in cerebral smooth muscle with renal hypertension. Circulation Research 1998 82 12 1330 1337 2-s2.0-0032577737 (Pubitemid 28294753)
46. Pesic A., Madden J. A., Pesic M., Rusch N. J., High blood pressure upregulates arterial L-type Ca2+ channels: is membrane depolarization the signal? Circulation research 2004 94 10 e97 e104 2-s2.0-4944263824
47. Pratt P. F., Bonnet S., Ludwig L. M., Bonnet P., Rusch N. J., Upregulation of L-type Ca2+ channels in mesenteric and skeletal arteries of SHR. Hypertension 2002 40 2 214 219 2-s2.0-0036330330 10.1161/01.HYP.0000025877. 23309.36 (Pubitemid 34840101)
48. Triggle D. J., L-type calcium channels. Current Pharmaceutical Design 2006 12 4 443 457 2-s2.0-33644906392 10.2174/138161206775474503
49. Zhou Z. H., Wang J., Xiao H., Chen Z. J., Wang M., Cheng X., Liao Y. H., A novel autoantibody in patients with primary hypertension: antibody against L-type Ca2+ channel. Chinese Medical Journal 2008 121 16 1513 1517 2-s2.0-52949110910
50. Bason C., Lorini R., Lunardi C., Dolcino M., Giannattasio A., d'Annunzio G., Rigo A., Pedemonte N., Corrocher R., Puccetti A., In type 1 diabetes a subset of anti-coxsackievirus B4 antibodies recognize autoantigens and induce apoptosis of pancreatic beta cells. PLoS ONE 2013 8 2 2-s2.0-84874571737 10.1371/journal.pone.0057729 e57729
51. Schlesinger M. J., Heat shock proteins. Journal of Biological Chemistry 1990 265 21 12111 12114 2-s2.0-0025330639
52. Xu Q., Schett G., Li C., Hu Y., Wick G., Mechanical stress-induced heat shock protein 70 expression in vascular smooth muscle cells is regulated by rac and ras small G proteins but not mitogen-activated protein kinases. Circulation Research 2000 86 11 1122 1128 2-s2.0-0034625555 (Pubitemid 30396036)
53. Xu Q., Li D. G., Holbrook N. J., Udelsman R., Acute hypertension induces heat-shock protein 70 gene expression in rat aorta. Circulation 1995 92 5 1223 1229 2-s2.0-0029097150
54. Liao D. F., Jin Z. G., Baas A. S., Daum G., Gygi S. P., Aebersold R., Berk B. C., Purification and identification of secreted oxidative stress-induced factors from vascular smooth muscle cells. Journal of Biological Chemistry 2000 275 1 189 196 2-s2.0-0034614624 10.1074/jbc.275.1.189 (Pubitemid 30038971)
55. Parra G., Quiroz Y., Salazar J., Bravo Y., Pons H., Chavez M., Johnson R. J., Rodriguez-Iturbe B., Experimental induction of salt-sensitive hypertension is associated with lymphocyte proliferative response to HSP70. Kidney International 2008 74 111 S55 S59 2-s2.0-57049142571 10.1038/ki.2008.513
56. Ishizaka N., Aizawa T., Ohno M., Usui S. I., Mori I., Tang S. S., Ingelfinger J. R., Kimura S., Nagai R., Regulation and localization of HSP70 and HSP25 in the kidney of rats undergoing long-term administration of Angiotensin II. Hypertension 2002 39 1 122 128 2-s2.0-0036150632 10.1161/hy1201.096818 (Pubitemid 34098100)
57. Pons H., Ferrebuz A., Quiroz Y., Romero-Vasquez F., Parra G., Johnson R. J., Rodriguez-Iturbe B., Immune reactivity to heat shock protein 70 expressed in the kidney is cause of salt-sensitive hypertension. The American Journal of Physiology-Renal Physiology 2013 304 3 F289 F299 2-s2.0-84873280995 10.1152/ajprenal.00517.2012
58. Molvarec A., Prohászka Z., Nagy B., Szalay J., Füst G., Karádi I., Rigó J. Jr., Association of elevated serum heat-shock protein 70 concentration with transient hypertension of pregnancy, preeclampsia and superimposed preeclampsia: a case-control study. Journal of Human Hypertension 2006 20 10 780 786 2-s2.0-33748949102 10.1038/sj.jhh.1002060 (Pubitemid 44430677)
59. Wu T., Ma J., Chen S., Association of plasma antibodies against the inducible Hsp70 with hypertension and harsh working conditions. Cell Stress & Chaperones 2001 6 4 394 401 (Pubitemid 33123493)
60. Pockley A. G., de Faire U., Kiessling R., Lemne C., Thulin T., Frostegård J., Circulating heat shock protein and heat shock protein antibody levels in established hypertension. Journal of Hypertension 2002 20 9 1815 1820 2-s2.0-0036735871 10.1097/00004872-200209000-00027
61. Molvarec A., Derzsy Z., Kocsis J., Bäze T., Nagy B., Balogh K., Makó V., Cervenak L., Mézes M., Karádi I., Prohászka Z., Rigó J. Jr., Circulating anti-heat-shock-protein antibodies in normal pregnancy and preeclampsia. Cell Stress and Chaperones 2009 14 5 491 498 2-s2.0-77950867192 10.1007/s12192-009-0102-4
62. Wu R., de Faire U., Lemne C., Witztum J. L., Frostegård J., Autoantibodies to OxLDL are decreased in individuals with borderline hypertension. Hypertension 1999 33 1 I 53 59 2-s2.0-0032950484 (Pubitemid 29061841)
63. Frostegard J., Wu R., Lemne C., Circulating oxidized low-density lipoprotein is increased in hypertension. Clinical Science 2003 105 5 615 620 10.1042/CS20030152 (Pubitemid 37421657)
64. Papadopoulos D. P., Makris T. K., Krespi P., Papazachou U., Stavroulakis G., Hatzizacharias A., Votteas V., Antiendothelial cell antibody levels in healthy normotensives with high normal blood pressure. Clinical and Experimental Hypertension 2006 28 8 663 667 2-s2.0-33751561957 10.1080/10641960601013567 (Pubitemid 44846986)
65. Papadopoulos D. P., Makris T. K., Papazachou U., Daskalaki M., Sanidas E., Votteas V. E., Antiendothelial cell antibody levels in patients with masked hypertension. International Journal of Cardiology 2008 130 3 405 408 2-s2.0-55549091392 10.1016/j.ijcard.2007.08.122
66. Frostegård J., Wu R., Gillis-Haegerstrand C., Lemne C., de Faire U., Antibodies to endothelial cells in borderline hypertension. Circulation 1998 98 11 1092 1098 2-s2.0-0032530255 (Pubitemid 28420701)
67. Rappaport V. J., Hirata G., Yap H. K., Jordan S. C., Anti-vascular endothelial cell antibodies in severe preeclampsia. The American Journal of Obstetrics and Gynecology 1990 162 1 138 146 2-s2.0-0025121986 (Pubitemid 20055437)
68. Harrison D. G., Guzik T. J., Lob H. E., Madhur M. S., Marvar P. J., Thabet S. R., Vinh A., Weyand C. M., Inflammation, immunity, and hypertension. Hypertension 2011 57 2 132 140 2-s2.0-79551490166 10.1161/HYPERTENSIONAHA.110. 163576
69. Harrison D. G., Vinh A., Lob H., Madhur M. S., Role of the adaptive immune system in hypertension. Current Opinion in Pharmacology 2010 10 2 203 207 10.1016/j.coph.2010.01.006
70. Oldstone M. B., Molecular mimicry and immune-mediated diseases. The FASEB Journal 1998 12 13 1255 1265 2-s2.0-0031664697 (Pubitemid 28475568)
71. Herse F., Verlohren S., Wenzel K., Pape J., Muller D. N., Modrow S., Wallukat G., Luft F. C., Redman C. W. G., Dechend R., Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009 53 2 393 398 2-s2.0-59849123575 10.1161/HYPERTENSIONAHA.108.124115
72. Kerr J. R., Parvovirus B19 infection. European Journal of Clinical Microbiology and Infectious Diseases 1996 15 1 10 29 2-s2.0-0030070045 10.1007/BF01586181 (Pubitemid 26051258)
73. Lunardi C., Tinazzi E., Bason C., Dolcino M., Corrocher R., Puccetti A., Human parvovirus B19 infection and autoimmunity. Autoimmunity Reviews 2008 8 2 116 120 2-s2.0-56349155359 10.1016/j.autrev.2008.07.005
74. Lamarca B., Wallace K., Granger J., Role of angiotensin II type i receptor agonistic autoantibodies (AT1-AA) in preeclampsia. Current Opinion in Pharmacology 2011 11 2 175 179 2-s2.0-79954420257 10.1016/j.coph.2011.01.003
75. Liu L., Liu Y., Tong W., Ye H., Zhang X., Cao W., Zhang Y., Pathogen burden in essential hypertension. Circulation Journal 2007 71 11 1761 1764 2-s2.0-36949028973 10.1253/circj.71.1761 (Pubitemid 350240099)
76. Ferrari I., Levin M. J., Wallukat G., Blies R., Lebesgue D., Chiale P., Elizari M., Rosenbaum M., Hoebeke J., Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human β 1-adrenergic receptor. Journal of Experimental Medicine 1995 182 1 59 65 2-s2.0-0029041334 10.1084/jem.182.1.59
77. Lopez Bergami P., Scaglione J., Levin M. J., Antibodies against the carboxyl-terminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. The FASEB Journal 2001 15 14 2602 2612 2-s2.0-0035199356 10.1096/fj.01-0132com (Pubitemid 33131087)
78. Kaplan D., Ferrari I., Bergami P. L., Mahler E., Levitus G., Chiale P., Hoebeke J., van Regenmortel M. H. V., Levin M. J., Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proceedings of the National Academy of Sciences of the United States of America 1997 94 19 10301 10306 2-s2.0-0030885253 10.1073/pnas.94.19.10301 (Pubitemid 27407036)
79. Mijares A., Verdot L., Peineau N., Vray B., Hoebeke J., Argibay J., Antibodies from Trypanosoma cruzi infected mice recognize the second extracellular loop of the β 1-adrenergic and M2-muscarinic receptors and regulate calcium channels in isolated cardiomyocytes. Molecular and Cellular Biochemistry 1996 163-164 107 112 2-s2.0-0029730836 (Pubitemid 26421491)
80. Malo M. E., Fliegel L., Physiological role and regulation of the Na+/H+ exchanger. Canadian Journal of Physiology and Pharmacology 2006 84 11 1081 1095 2-s2.0-33947531619 10.1139/Y06-065 (Pubitemid 46465921)
81. Rosskopf D., Dusing R., Siffert W., Membrane sodium-proton exchange and primary hypertension. Hypertension 1993 21 5 607 617 2-s2.0-0027483289 (Pubitemid 23120214)
82. Rosskopf D., Fromter E., Siffert W., Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension. Journal of Clinical Investigation 1993 92 5 2553 2559 2-s2.0-0027360015 (Pubitemid 23333567)
83. Rosskopf D., Hartung K., Hense J., Siffert W., Enhanced immunoglobulin formation of immortalized B cells from hypertensive patients. Hypertension 1995 26 3 432 435 2-s2.0-0029116762
84. Siffert W., Rosskopf D., Moritz A., Wieland T., Kaldenberg-Stasch S., Kettler N., Hartung K., Beckmann S., Jakobs K. H., Enhanced G protein activation in immortalized lymphoblasts from patients with essential hypertension. Journal of Clinical Investigation 1995 96 2 759 766 2-s2.0-0029114106
85. Phan V. N., Kusuhara M., Lucchesi P. A., Berk B. C., A 90-kD NA+-H+ exchanger kinase has increased activity in spontaneously hypertensive rat vascular smooth muscle cells. Hypertension 1997 29 6 1265 1272 2-s2.0-0030922463 (Pubitemid 27233175)
86. Takahashi E., Abe J. I., Berk B. C., Angiotensin II stimulates p90(rsk) in vascular smooth muscle cells: a potential Na+-H+ exchanger kinase. Circulation Research 1997 81 2 268 273 2-s2.0-0030857877 (Pubitemid 27342494)
87. Gunasegaram S., Haworth R. S., Hearse D. J., Avkiran M., Regulation of sarcolemmal Na+/H+ exchanger activity by angiotensin II in adult rat ventricular myocytes opposing actions via AT1 versus AT2 receptors. Circulation Research 1999 85 10 919 930 2-s2.0-0032695140 (Pubitemid 29534167)
88. Zhang J. D., Patel M. B., Song Y. S., Griffiths R., Burchette J., Ruiz P., Sparks M. A., Yan M., Howell D. N., Gomez J. A., Spurney R. F., Coffman T. M., Crowley S. D., A Novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. Circulation Research 2012 110 12 1604 1617 2-s2.0-84862296510 10.1161/CIRCRESAHA.111.261768
89. Guzik T. J., Hoch N. E., Brown K. A., McCann L. A., Rahman A., Dikalov S., Goronzy J., Weyand C., Harrison D. G., Role of the T cell in the genesis of angiotensin II-induced hypertension and vascular dysfunction. Journal of Experimental Medicine 2007 204 10 2449 2460 2-s2.0-34948825774 10.1084/jem.20070657 (Pubitemid 47529329)
90. Lagresle-Peyrou C., Yates F., Malassis-Séris M., Hue C., Morillon E., Garrigue A., Liu A., Hajdari P., Stockholm D., Danos O., Lemercier B., Gougeon M. L., Rieux-Laucat F., de Villartay J. P., Fischer A., Cavazzana-Calvo M., Long-term immune reconstitution in RAG-1-deficient mice treated by retroviral gene therapy: a balance between efficiency and toxicity. Blood 2006 107 1 63 72 2-s2.0-30144444329 10.1182/blood-2005-05-2032 (Pubitemid 43053525)
91. Novotny S. R., Wallace K., Heath J., Moseley J., Dhillon P., Weimer A., Wallukat G., Herse F., Wenzel K., Martin J. N. Jr., Dechend R., LaMarca B., Activating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic rats. The American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2012 302 10 R1197 R1201 2-s2.0-84861154898 10.1152/ajpregu.00623.2011
92. Maurer P., Bachmann M. F., Immunization against angiotensins for the treatment of hypertension. Clinical Immunology 2010 134 1 89 95 2-s2.0-71649090306 10.1016/j.clim.2009.06.003
93. Do T. H., Chen Y., Nguyen V. T., Phisitkul S., Vaccines in the management of hypertension. Expert Opinion on Biological Therapy 2010 10 7 1077 1087 10.1517/14712598.2010.487060
94. Brown M. J., Success and failure of vaccines against renin-angiotensin system components. Nature Reviews Cardiology 2009 6 10 639 647 2-s2.0-77649314549
95. Ramos-Casals M., Sanz I., Bosch X., Stone J. H., Khamashta M. A., B-cell-depleting therapy in systemic lupus erythematosus. The American Journal of Medicine 2012 125 4 327 336 2-s2.0-84858986751 10.1016/j.amjmed.2011.09.010
96. Esler M. D., Krum H., Schlaich M., Schmieder R. E., Böhm M., Sobotka P. A., Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the symplicity htn-2 randomized, controlled trial. Circulation 2012 126 25 2976 2982 2-s2.0-84871312992 10.1161/ CIRCULATIONAHA.112.130880
97. Bhatt D. L., Kandzari D. E., O'Neill W. W., A controlled trial of renal denervation for resistant hypertension. The New England Journal of Medicine 2014 370 15 1393 1401 10.1056/NEJMoa1402670